CHS Announces New Cancer Research Partnership
CHS has joined the Roswell Park Care Network (RPCN) and is participating in the first of many exclusive clinical trials designed to assess new therapies for cancer patients. This partnership offers unique opportunities for studies related to the latest research in the field of cancer treatments.
Founded in 1898, Roswell Park Comprehensive Cancer Center was the first facility in the world to focus exclusively on cancer. In 1972, Roswell was one of three National Cancer Institute designated comprehensive cancer centers—a status it maintains today—and was recently recognized by U.S. News & World Report as among the Best Hospitals in the nation for cancer for 2019–2020. Based in Buffalo, New York, the RPCN engages key providers throughout the state to make proprietary studies available to qualifying patients across a wider geographical area. CHS is the downstate region’s only RPCN member and is now also affiliated with the Alliance for Clinical Trials in Oncology.
CHS has initiated its first study with Roswell Park Comprehensive Cancer Center at its Cancer Institute at St. Francis Hospital in East Hills. The Phase 2 Study of Targeting CD28 in Multiple Myeloma with Abatacept to Overcome Resistance to Chemotherapy is being conducted by CHS’s Chair of Cancer Services Bhoomi Mehrotra, MD, with St. Francis’s Director of Malignant Hematology Dilip Patel, MD, as the principal investigator. This trial will be added to St. Francis Hospital’s many other groundbreaking trials in various fields of medicine.
“Our partnership with Roswell will give cancer patients in our region access to several innovations,” said Mehrotra. “There have been major advances in oncology within the past few years, and all of those advances have happened by individuals participating in clinical trials.”
CHS recently opened a new facility for its Cancer Institute at Good Samaritan Hospital Medical Center in West Islip. The center is staffed by expert oncologists, surgeons, nurses and other clinicians specializing in comprehensive cancer care. Good Samaritan’s cancer program is 1 of only 7 nationwide to have earned the Outstanding Achievement Award from the American College of Surgeons Commission on Cancer for 15 years in a row. CHS’s Cancer Institute at Mercy Medical Center in Rockville Centre will open soon, as well, to help address the needs of patients and families in the surrounding communities.
Also, the health system continues to enhance its existing programs. This includes expanding cancer screening programs, hiring disease-specific surgical oncologists where needed and adding oncologists at St. Francis and the CHS Cancer Center at St. Joseph Hospital, in Bethpage, to meet patient demand. In Suffolk, St. Catherine of Siena Medical Center and St. Charles Hospital offer surgical oncology and radiology services, with additional services in development.
To learn more about cancer care programs available to Long Islanders and future trials at CHS in partnership with Roswell Park, please visit CHSCancer.org or call (844) 86-CANCER.